Abstract
A dosimetric analysis was undertaken on lung cancer patients previously treated with 3D-conformal stereotactic ablative radiotherapy (SABR). Dynamic conformal arc therapy (DCAT) and volumetric modulated arc therapy (VMAT) treatment-plans were created for the same patients and compared to the original treatment DCAT was found to be superior to 3D CRT and comparable to VMAT dosimetrically. Measurements incorporating breathing-motion demonstrated evidence for the interplay effect in the VMAT plans but wasn't seen in either 3D-CRT or DCAT. Ease of planning, dosimetric quality, fast treatment-times and robustness of delivery when motion is present make DCAT the favoured modality for SABR lung treatments.
Original language | English |
---|---|
Qualification | Masters |
Awarding Institution |
|
Supervisors/Advisors |
|
Award date | 8 Dec 2017 |
DOIs | |
Publication status | Unpublished - 2017 |